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Background. Changes in hepatosplanchnic lactate exchange are likely to contribute to hyperlactatemia in sepsis. We hypothesized
that septic and cardiogenic shock have different effects on hepatosplanchnic lactate exchange and its contribution to hyperlac-
tatemia. Materials and Methods. 24 anesthetized pigs were randomized to fecal peritonitis (P), cardiac tamponade (CT), and to
controls (𝑛 = 8 per group). Oxygen transport and lactate exchange were calculated during 24 hours. Results.While hepatic lactate
influx increased in P and in CT, hepatic lactate uptake remained unchanged in P and decreased in CT. Hepatic lactate efflux
contributed 20% (P) and 33% (CT), respectively, towhole body venous efflux.Despitemaintained hepatic arterial blood flow, hepatic
oxygen extraction did not increase in CT. Conclusions.Whole body venous lactate efflux is of similar magnitude in hyperdynamic
sepsis and in cardiogenic shock. Although jejunal mucosal pCO
2
gradients are increased, enhanced lactate production from other
tissues is more relevant to the increased arterial lactate. Nevertheless, the liver fails to increase hepatic lactate extraction in response
to rising hepatic lactate influx, despite maintained hepatic oxygen consumption. In cardiac tamponade, regional, extrasplanchnic
lactate production is accompanied by hepatic failure to increase oxygen extraction andnet hepatic lactate output, despitemaintained
hepatic arterial perfusion.
1. Introduction
Hyperlactatemia is a common finding in patients with
sepsis and multiple organ failure and is associated with
increased morbidity and mortality [1–3]. If such patients
are well fluid resuscitated, systemic blood flow and oxygen
delivery to the tissues are often high. Despite this, organ
dysfunction and mild to moderate hyperlactatemia may
persist.
In clinical practice, hyperlactatemia, especially in com-
bination with metabolic acidosis, is commonly interpreted
as sign of tissue hypoxia [4–7]. If sepsis is associated with
hyperdynamic circulation, increased lactate production due
to enhanced glycolytic metabolism, decreased oxygen extrac-
tion capability, and/or lactate clearance, and pyruvate dehy-
drogenase inactivation may offer alternative explanations
for hyperlactatemia [8–12]. However, as a consequence of
regional blood flow redistribution and metabolic compart-
mentalization, high systemic blood flow may not necessarily
guarantee sufficient oxygen delivery to all tissues [13, 14].
In addition, sepsis often alters the function of organs which
usually extract lactate, such as the liver and the kidneys. This
may result in hyperlactatemia even in the presence of normal
or only slightly increased lactate production. In contrast, in
severe low cardiac output states, hyperlactatemia is likely
to result from anaerobic metabolism and impaired lactate
extraction due to generalized tissue hypoperfusion [15].
The aim of this study was to evaluate the contribution
of hepatosplanchnic and extrahepatic lactate exchange to
arterial hyperlactatemia in fecal peritonitis and cardiac tam-
ponade. We hypothesized that the increase in arterial lactate
concentration in fecal peritonitis is the result of a generalized
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increase in lactate productionwithmaintained hepatic lactate
uptake.
2. Materials and Methods
2.1. Anesthesia, Monitoring, and Animal Preparation. The
study was performed in accordance with the National Insti-
tutes ofHealth guidelines for the care and use of experimental
animals andwith the approval of theAnimal Care Committee
of the Canton of Berne, Switzerland. Here, we present data
from a subset of animals from two previous publications,
where effects of fluid resuscitation on mortality and organ
function in sepsis [16] and oxygen transport and mitochon-
drial function in shock models [17] were investigated.
24 pigs (median body weight 41 kg, range 38–44 kg) were
deprived of food but not water 24 hrs before the experi-
ment. They were premedicated with atropine 0.05mg/kg of
body weight, azaperone 6 xylazine 2mg/kg, and ketamine
20mg/kg intramuscularly, followed by cannulation of an
ear vein and intravenous administration of 5–15mg/kg pen-
tobarbital and atropine 0.05mg/kg followed by tracheal
intubation. Anesthesia was maintained with pentobarbital
7mg/kg hour and fentanyl 25 𝜇g/kg hour until the end
of the operation and thereafter 3 𝜇g/kg hour. The animals
were ventilated with a volume controlled ventilator with
5 cm of H
2
O end-expiratory pressure. FIO
2
was adjusted
to keep paO
2
between 100mmHg and 150mmHg. Tidal
volume was kept at 10mL/kg, and the minute ventilation
was adjusted to maintain paCO
2
between 35 and 40mmHg.
A pulmonary artery catheter and a femoral arterial catheter
were inserted. Ringer’s lactate was infused at 10mL/kg hour.
Additional fluid was administered if necessary to keep pul-
monary capillary wedge pressure between 5 and 8mmHg.
The aim was to keep the body temperature at 38 ± 0.5∘C
using and operating table heater and warmed fluids if
necessary.
2.2. Surgical Preparation. The carotid artery was exposed,
and an ultrasound flow probe was placed around the artery
(Transonic Systems, Ithaca, NY, USA). A large bore catheter
for fluid administration was inserted into the femoral vein.
The abdominal cavity was opened by a midline incision.
A drainage catheter was inserted into the urinary bladder.
The superior mesenteric, hepatic, splenic, and renal artery,
the celiac trunk, and the portal vein were exposed, and
ultrasound flow probes were placed around the vessels. Two
fluid filled catheters were inserted into a mesenteric vein.
The tip of the first catheter was placed into the portal
vein, while the tip of the second catheter remained in the
mesenteric vein. A catheter was inserted into the splenic
vein and another catheter into the hepatic artery via the
left gastric artery. A hepatic vein catheter was inserted, and
the location of the tip was confirmed by ultrasound and
oxygen vein saturation. The catheter was withdrawn 0.5 cm
from the wedged position to allow measurement of hepatic
venous pressure and saturation.A central venous catheterwas
inserted into the pericardial space via dissection of the left
diaphragm. Before closing the laparotomy with clamps, two
large bore tubes were placed with their tips in the peritoneal
cavity to allow later insertion of autologous feces.
2.3. Hemodynamic Monitoring. Femoral and pulmonary
arterial, central, hepatic, and portal venous blood pressures
and pulmonary artery occlusion pressure were recorded with
quartz pressure transducers and displayed continuously on a
multimodular monitor (S/5 Compact Critical Care monitor,
GE,Helsinki, Finland) and recorded.All pressure transducers
were zeroed to the level of the heart. Cardiac output wasmea-
sured by a thermodilution technique (mean value of three
measurements, cardiac output module, S/5) and by using
an esophageal Doppler probe (Cardio Q, Deltex Medical
limitex, Chichester, UK). Central venous blood temperature
(∘C) was recorded from the thermistor in the pulmonary
artery catheter and peripheral temperature from a thermistor
placed between the toes. Regional blood flows were recorded
by ultrasound transit time flow probes (Transonic Systems,
Ithaca, NY, USA). Heart rate was measured from the ECG
wich was also continuously monitored.
2.4. Experimental Protocol. After surgical preparation, 12
hours were allowed for hemodynamic stabilization. The ani-
mals were randomized into three different groups: peritonitis
(𝑛 = 8), cardiac tamponade (𝑛 = 8), and controls
(𝑛 = 8). Peritonitis was induced by instilling 1 g/kg of
autologous feces suspended in warm 5% dextrose solution
through a previously placed peritoneal drainage tube. Cardiac
tamponade was induced by instilling warmed hydroxyethyl
starch into the pericardial space with goals of cardiac output
of 60mL/kg/min during the first 6 hours, 50mL/kg/min
from 6 to 12 hours, and 40mL/kg/min from 12 to 18 hours.
Afterwards, cardiac output was not manipulated anymore.
When clinical signs of hypovolemia developed in any
group of the animals (rapidly decreasing blood pressure,
increasing heart rate or urinary output <0.5mL/kg/hr, and
pulmonary artery occlusion pressure <5mmHg), additional
aliquots of hydroxyethyl starch were infused. Glucose 50%
was administered when blood glucose was <3.5mmol/L.
Animals surviving 24 hours were sacrificed with an overdose
of intravenous potassium chloride.
2.5. Blood Measurements. Arterial hemoglobin and oxygen
haemoglobin saturation were analyzed with an analyzer
designed for porcine blood (OSM3, Radiometer, Copen-
hagen, Denmark). Blood gases were measured and tempera-
ture corrected in a blood gas analyzer (ABL 520, Radiometer,
Copenhagen, Denmark). Arterial and venous blood lactate
were measured with a lactate analyzer (YSI 2300 Stat Plus,
Yellow Springs Instruments, CA, USA).
2.6. Calculations and Statistics. Hepatic lactate influx
(𝜇mol/kg/min) = (portal venous lactate × portal vein blood
flow) + (arterial lactate × hepatic arterial blood flow).
Hepatic lactate efflux (𝜇mol/kg/min) = hepatic venous
lactate × (portal venous + hepatic arterial blood flow).
Hepatic lactate uptake (𝜇mol/kg/min) = hepatic lactate
influx − hepatic lactate efflux.
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Hepatic lactate extraction (%) = hepatic lactate
efflux/hepatic lactate influx.
Other regional lactate exchanges: regional lactate influx −
regional lactate efflux.
Area under arterial lactate concentration-time curve
(mmol/L): sum of products of average of two consecutive lac-
tate concentrations and time between the twomeasurements,
divided by total time of experiment (mmol/L).
Whole body venous efflux: cardiac output×mixed venous
lactate concentration. Extrahepatic organ lactate efflux: (car-
diac output ×mixed venous lactate concentration) − hepatic
lactate efflux.
For statistical analysis, the SPSS software package (SPSS
version 14.1, SPSS SchweizAG,Zurich, Switzerland)was used.
In each group, nonparametric ANOVA for repeatedmeasure-
ments (Friedman test) was used to evaluate evolution over
time. There was significant 24 hours mortality in peritonitis
and tamponade groups. To ensure that the same number of
measurements from each animal was available, only the last
of the remaining measurements between 12 hours and 24
hours was used for analysis. For between-group comparison
of variables with only one measurement, Kruskal Wallis test
was employed. Statistical significance was set at 𝑃 = 0.05. All
results are presented as median and range.
3. Results
In both study groups, 4 animals died before 24 hours.
3.1. Systemic Hemodynamics and Oxygen Transport. In both
peritonitis and cardiac tamponade, shock ensued (Table 1).
There was a transient increase in cardiac output in peritonitis
and a decrease in cardiac tamponade. Systemic oxygen
consumption was maintained in all groups (Table 1).
3.2. Lactate Concentrations. Arterial and all regional lactate
concentrations increased in peritonitis and in cardiac tam-
ponade (Table 2). The area under the lactate concentration-
time curve was 0.6 (0.5–1.1)mmol/L, 1.3 (0.9–1.7)mmol/L,
and 1.3 (0.5–2.4)mmol/L for control, peritonitis, and cardiac
tamponade groups, respectively (𝑃 = 0.005 for the compari-
son between all three groups).
3.3. Lactate Exchange. Mesenteric lactate exchange—which
was slightly negative at baseline (lactate release)—became
early and transiently less negative in peritonitis (𝑃 = 0.031)
and turned positive (lactate uptake) in the end in two thirds
of the animals with tamponade (n.s.; ES-Figure 1 available
online at http://dx.doi.org/10.1155/2013/251084). Renal lactate
exchangewas variable anddid not change in either group (ES-
Figure 2).
Hepatic lactate influx increased early in peritonitis and
late in cardiac tamponade (Figure 1;𝑃 = 0.001, both).Hepatic
lactate uptake remained unchanged in control and peritonitis
groups but turned to lactate release in all but two animals
with cardiac tamponade (𝑃 = 0.006; Figure 2). Hepatic
lactate efflux increased significantly in cardiac tamponade
(𝑃 < 0.001) and tended to increase in peritonitis (𝑃 = 0.057;
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Figure 1: Hepatic lactate influx. ∗Friedmann test.
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Figure 2: Hepatic lactate uptake. ∗Friedmann test.
ES-Figure 3). Extrahepatic organ lactate efflux (Figure 3) and
whole body venous lactate efflux (ES-Figure 4) increased
both in peritonitis and in cardiac tamponade (all 𝑃 < 0.012).
3.4. Regional Blood Flows and Oxygen Transport. In peri-
tonitis, renal blood flow tended to decrease (𝑃 = 0.052),
while all other regional flows were maintained (Table 3).
In tamponade, celiac trunk and hepatic arterial blood flow
were maintained, while all other regional flows decreased
(Table 3). In peritonitis, all regional VO
2
were maintained
(ES-Table 1). In tamponade, oxygen extraction increased in
all regions/organs but the liver. Only renal VO
2
decreased
significantly (ES-Table 1).
3.5. Regional and Mucosal pCO
2
Gradients. In peritoni-
tis, mixed and hepatic venous-arterial and mucosal-arterial
pCO
2
gradients increased, while all other regional pCO
2
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Table 1: Systemic hemodynamics and oxygen transport.
𝑁 Baseline 3 hours 6 hours 12 hours Last measurement 𝑃∗
Cardiac output
(mL/kg/min)
Controls 8 89 (69–116) 91 (48–117) 98 (56–121) 92 (66–58) 108 (67–127) 0.344
Peritonitis 8 90 (55–107) 87 (63–154) 114 (74–151) 82 (49–133) 102 (80–146) 0.060
Tamponade 7 73 (54–101) 60 (38–76) 57 (53–76) 53 (47–81) 46 (38–62) 0.004
Central venous pressure
(mmHg)
Controls 8 4 (2–6) 4 (2–7) 5 (3–8) 5 (3–7) 8 (5–9) 0.001
Peritonitis 8 4 (0–5) 3 (1–5) 4 (2–6) 6 (3–9) 7 (4–10) <0.001
Tamponade 7 5 (3–9) 7 (4–9) 7 (6–10) 11 (7–15) 13 (12–16) <0.001
Mean arterial pressure
(mm Hg)
Controls 8 72 (61–82) 70 (52–91) 71 (56–89) 78 (64–81) 74 (50–91) 0.623
Peritonitis 8 67 (61–92) 76 (54–92) 63 (54–88) 66 (49–89) 42 (34–90) 0.048
Tamponade 7 80 (52–88) 66 (57–93) 64 (52–84) 56 (38–88) 36 (33–64) <0.001
Systemic oxygen
consumption
(mL/kg/min)
Controls 8 4.76 (3.66–5.45) 4.42 (3.26–5.75) 4.70 (3.25–6.49) 4.78 (3.37– 11.31) 4.56 (3.22–5.45) 0.861
Peritonitis 8 4.96 (2.50–5.98) 5.38 (4.20–7.86) 5.99 (4.39–6.88) 5.29 (3.19–6.14) 5.59 (3.55–6.43) 0.199
Tamponade 7 4.17 (3.31–5.35) 4.07 (2.75–5.63) 3.87 (3.39–5.82) 4.35 (3.80–6.67) 4.17 (2.85–7.12) 0.966
Systemic oxygen
extraction
Controls 8 0.43 (0.34–0.54) 0.41 (0.29–0.61) 0.47 (0.31–0.54) 0.46 (0.29–0.54) 0.42 0.28–0.51) 0.995
Peritonitis 8 0.48 (0.36–0.59) 0.39 (0.31–0.42) 0.35 (0.29–0.50) 0.44 (0.33–0.66) 0.50 (0.32–0.66) 0.053
Tamponade 7 0.48 (0.39–0.59) 0.54 (0.45–0.67) 0.59 (0.43–0.67) 0.62 (0.55–0.75) 0.82 (0.73–0.94) <0.001
∗Friedman test.
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Figure 3: Extrahepatic organ lactate efflux. ∗Friedmann test.
gradients remained unchanged (ES-Table 2). In tamponade,
jejunal mucosal and all regional venous-arterial pCO
2
gradi-
ents increased (ES-Table 2).
4. Discussion
Our data indicate that the whole body venous lactate efflux
as an estimate of hepatic and extrahepatic organ lactate efflux
is of similar magnitude in the experimental models of severe
peritonitis-induced sepsis and cardiac tamponade. However,
changes in arterial lactate over time were due to different
mechanisms.
In peritonitis, whole body venous efflux increased early,
mainly due to extrasplanchnic, extrarenal lactate produc-
tion, and the liver lactate uptake was preserved. Unchanged
regional pCO
2
gradients and maintained regional oxygen
consumption suggest that increased glycolysis rather than
tissue hypoxia was the cause of increased lactate efflux.
Despite a decrease in renal blood flow and an increase in
local jejunal-mucosal pCO
2
gradient, renal and mesenteric
lactate exchange did not deteriorate, indicating that impaired
perfusion in these regions was not critical either.
In contrast, in cardiac tamponade, extrasplanchnic lactate
production increased, and the hepatic lactate uptake reverted
to net hepatic lactate efflux.The net hepatic lactate output was
associated with a lack of increase in hepatic oxygen extrac-
tion. Although hepatic arterial perfusion was preserved,
portal venous blood flow and oxygen content decreased
markedly. We have previously demonstrated that hepatic
lactate uptake can increase acutely by several folds, if hepatic
perfusion is preserved [18, 19]. The failure of hepatic lactate
uptake to increase in cardiac tamponade in the present study
is likely explained by the decrease of hepatic perfusion and
oxygen delivery below a critical level. We found previously in
an acute short-term (150 minutes) cardiac tamponade model
that hepatic lactate exchange decreased when hepatic oxygen
delivery decreased to approximately 20% of control values (a
mean of 0.3mL/kg/min) [15]. In the present study, the sus-
tained reduction of hepatic oxygen delivery to approximately
30% of the control values (a mean of 0.6mL/kg/min) was
associated with an average hepatic oxygen extraction of 0.75
and resulted in net hepatic lactate production. All regional
pCO
2
gradients increased, but the mesenteric (and femoral)
lactate gradient did not increase. Accordingly, the decreased
regional blood flows did not induce severe mesenteric tissue
hypoxia. Hence, the net hepatic lactate production was a
result of enhanced extra-mesenteric lactate efflux and hepatic
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Table 2: Arterial, mixed and regional venous lactate concentrations.
𝑁 Baseline 3 hours 6 hours 12 hours Lastmeasurement 𝑃
∗
Arterial lactate
concentration
Controls 8 0.557(0.439–0.999)
0.505
(0.160–0.766)
0.555
(0.451–1.880)
0.611
(0.453–0.863)
0.658
(0.450–0.993) 0.793
Peritonitis 7 0.586(0.391–0.960)
1.150
(0.679–2.270)
1.315
(0.614–2.200)
1.037
(0.721–2.010)
1.250
(0.972–2.720) 0.002
Tamponade 7 0.586(0.503–0.720)
0.600
(0.420–0.800)
0.650
(0.473–1.890)
0.935
(0.526–3.640)
3.560
(1.030–7.000) 0.001
Mixed venous
lactate
concentration
Controls 8 0.531(0.443–0.754)
0.504
(0.443–0.729)
0.587
(0.470–1.220)
0.638
(0.507–0.808)
0.681
(0.461–1.050) 0.645
Peritonitis 6 0.660(0.417–1.390)
1.195
(0.757–2.120)
1.140
(0.797–2.370)
1.110
(0.714–2.090)
1.425
(0.884–2.750) 0.015
Tamponade 7 0.600(0.481–0.829)
0.619
(0.471–0.800)
0.753
(0.520–1.750)
0.972
(0.532–3.360)
3.510
(1.000–8.300) 0.001
Hepatic vein
lactate
concentration
Controls 8 0.275(0.170–0.440)
0.270
(0.130–0.380)
0.325
(0.220–0.540)
0.310
(0.220–0.370)
0.375
(0.210–0.750) 0.502
Peritonitis 7 0.420(0.180–0.540)
0.860
(0.300–1.220)
0.840
(0.290–1.510)
0.745
(0.330–3.240)
0.910
(0.630–3.240) 0.010
Tamponade 7 0.295(0.200–0.894)
0.305
(0.180–0.643)
0.405
(0.250–1.170)
0.460
(0.200–3.090)
3.850
(0.640–8.400) 0.001
Portal vein
lactate
concentration
Controls 8 0.607(0.493–0.792)
0.626
(0.521–0.815)
0.666
(0.545–1.280)
0.682
(0.599–0.859)
0.793
(0.535–1.030) 0.273
Peritonitis 6 0.822(0.557–0.954)
1.350
(1.210–2.010)
1.390
(0.817–2.250)
1.390
(0.970–2.040)
1.650
(1.170–3.100) 0.001
Tamponade 6 0.699(0.556–0.894)
0.731
(0.582–1.000)
0.800
(0.532–1.900)
1.110
(0.716–3.430)
3.400
(1.140–6.700) 0.004
Mesenteric vein
lactate
concentration
Controls 8 0.622(0.427–0.807)
0.697
(0.504–0.777)
0.665
(0.553–1.250)
0.685
(0.590–0.823)
0.753
(0.591–1.030) 0.434
Peritonitis 6 0.946(0.586–1.380)
1.250
(0.882–1.840)
1.330
(0.816–3.510)
1.325
(1.020–2.360)
1.730
(1.020–2.970) 0.005
Tamponade 8 0.729(0.655–1.000)
0.846
(0.394–1.100)
0.780
(0.569–1.910)
1.140
(0.797–3.580)
2.715
(0.974–5.110) 0.002
Kidney vein
lactate
concentration
Controls 7 0.641(0.505–1.000)
0.602
(0.468–0.965)
0.660
(0.504–1.690)
0.706
(0.541–0.948)
0.801
(0.393–1.510) 0.273
Peritonitis 7 0.682(0.390–1.290)
1.270
(0.903–2.050)
1.590
(0.974–2.510)
0.928
(0.762–3.670)
1.210
(1.140–2.660) <0.001
Tamponade 6 0.475(0.409–0.919)
0.418
(0.372–0.800)
0.713
(0.418–1.860)
0.830
(0.401–2.830)
2.290
(0.634–7.000) 0.004
Femoral vein
lactate
concentration
Controls 8 0.919(0.506–1.480)
0.765
(0.567–1.120)
0.830
(0.621–2.510)
0.852
(0.715–1.530)
1.245
(0.643–2.210) 0.141
Peritonitis 5 0.834(0.595–2.010)
1.690
(0.966–3.490)
1.935
(1.080–2.530)
1.720
(1.110–2.410)
1.980
(1.220–2.610) 0.014
Tamponade 5 0.865(0.549–2.380)
0.935
(0.769–1.050)
1.030
(0.783–3.180)
1.900
(1.310–3.960)
3.420
(1.520–6.600) 0.005
Spleen vein
lactate
concentration
Controls 8 0.702(0.551–0.780)
0.758
(0.543–0.968)
0.759
(0.528–1.650)
0.699
(0.583–1.360)
0.742
(0.489–1.320) 0.393
Peritonitis 4 0.718(0.674–0.874)
1.720
(0.985–2.260)
1.650
(0.878–2.590)
1.645
(1.070–2.220)
1.860
(1.490–3.600) 0.007
Tamponade 6 0.714(0.569–1.000)
0.740
(0.708–1.140)
0.810
(0.640–1.960)
1.100
(0.636–3.770)
3.410
(1.550–8.300) 0.002
All concentrations are in mmol/L. ∗Friedman Test.
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Table 3: Regional blood flows.
𝑁 Baseline 3 hours 6 hours 12 hours Last measurement 𝑃∗
Superior
mesenteric
artery blood
flow
Controls 8 17.64 (10.12–25.15) 19.01 (8.77–26.34) 17.68 (9.12–28.60) 18.74 (11.54–26.34) 19.68 (11.02–35.61) 0.772
Peritonitis 8 16.06 (10.08–21.61) 14.32 (11.30–17.80) 16.12 (12.21–19.88) 15.23 (11.78–19.39) 16.37 (6.73–22.66) 0.897
Tamponade 7 17.29 (12.21–26.59) 14.51 (12.59–18.25 ) 15.69 (11.17–16.60) 13.40 (10.70–14.06) 11.90 (9.46–14.27 ) 0.050
Portal vein
blood flow
Controls 8 21.66 (13.00–26.37) 23.48 (12.31–29.77) 20.13 (12.51–33.94) 19.86 (14.21– 32.41) 24.53 (8.91–35.68) 0.974
Peritonitis 8 21.91 (15.06–29.55) 19.55 (10.49–31.14) 20.66 (8.95–25.23) 17.71 (8.31–30.23) 18.23 (7.31–27.27) 0.628
Tamponade 7 17.26 (14.50–30.57) 14.89 (10.68–20.75) 15.52 (9.93–19.41) 11.74 (6.40–16.18) 10.49 (7.67–15.21) 0.001
Renal artery
blood flow
Controls 7 5.02 (3.11–8.10) 4.97 (2.75–8.24) 4.66 (2.53–9.22) 4.63 (3.30–10.74) 5.93 (2.42–9.87) 0.767
Peritonitis 8 4.99 (3.65–8.06) 4.41(3.51–7.00) 4.07 (2.72–5.50) 4.39 (0.51–6.29) 3.82 (0.51–7.65) 0.052
Tamponade 7 5.05 (3.85–6.37) 3.85 (3.08–4.78) 3.75 (3.56–5.28) 3.13 (2.69–5.47) 1.53 (0.72–4.80) 0.001
Celiac trunk
blood flow
Controls 8 6.32 (2.26–14.58) 5.73 (2.26–20.80) 7.40 (2.89–18.93) 8.93 (4.11–19.85) 9.10 (6.56–16.93) 0.008
Peritonitis 8 7.70 (3.12–16.28) 8.20 (4.90–16.23) 8.53 (4.45–16.95) 11.61 (5.62–20.13) 10.00 (3.18–17.56) 0.701
Tamponade 7 7.37 (3.03–11.89) 6.54 (4.70–13.14) 6.71 (3.95–11.47) 5.78 (3.79–10.48) 5.25 (3.07–10.62) 0.788
Hepatic artery
blood flow
Controls 8 3.50 (0.71–5.27) 3.72 (0.63–8.45) 4.35 (0.87–7.87) 4.31 (1.33–7.59) 4.67 (1.95–6.03) 0.088
Peritonitis 8 3.51 (1.69–11.91) 3.47 (1.27–10.75) 3.20 (1.01–11.13) 5.10 (1.16–13.06) 3.91 (1.43–11.36) 0.111
Tamponade 7 2.48 (0.95–5.48) 3.06 (0.79–4.20) 3.21 (1.06–4.23) 2.45 (1.09–3.34) 1.58 (0.56–4.45) 0.613
Spleen artery
blood flow
Controls 8 1.20 (0.46–1.74) 1.15 (0.39–1.92) 1.20 (0.47–2.14) 1.19 (0.53–2.74) 1.42 (0.52–3.14) 0.146
Peritonitis 8 1.15 (0.71–1.55) 0.73 (0.36–1.47) 0.52 (0.22–2.04) 0.53 (0.21–2.29) 0.32 (0.02–2.09) 0.076
Tamponade 7 1.03 (0.73–1.79) 0.82 (0.54–1.05) 0.87 (0.47–1.42) 0.67(0.23–1.28) 0.38 (0.23–0.74) <0.001
All flows are in mL/kg/min. ∗Friedman test.
lactate production. At high arterial lactate concentrations
without mesenteric ischemia, the gut and other extrahepatic
tissues may even take up lactate [19, 20]. In the present study,
the arterial lactate concentrations remained only slightly or
moderately increased, and the extrahepatic tissues continued
to release lactate.
Despite the well-maintained hepatic perfusion in peri-
tonitis, the liver lactate uptake did not increase. We have
previously shown that hepatic lactate increases acutely during
hyperlactatemia induced by lactate infusion [19] and in
response to increased splanchnic lactate production during
acute mesenteric ischemia [18], providing that the hepatic
perfusion is preserved. The lack of increase in hepatic
lactate uptake in peritonitis may be related to either the
relatively modest increase in portal venous lactate, to sepsis-
induced impairment of hepatic function unrelated to tissue
perfusion, or to a combination of the two mechanisms.
Regardless of the mechanism(s), the increased whole body
lactate efflux in peritonitis was mainly due to increased
extrasplanchnic lactate production. The lack of increase in
regional pCO
2
-gradients suggests that the increased lactate
efflux was not related to impaired regional perfusion. The
etiology of hyperlactatemia in clinical sepsis without shock
is multifactorial, but it is rarely associated with an increase
in lactate to pyruvate ratio [21]. Accordingly, increased
aerobic lactate production due to increased glycolysis and
hypermetabolism or inhibition of pyruvate dehydrogenase
activity and hepatic dysfunction may contribute. Indeed, it
has been shown that stress-induced aerobic glycolysis in
skeletal muscle occurs in many forms of shock including
human and experimental septic shock and also hemorrhagic
shock [22, 23]. Under these circumstances, hyperlactatemia
(and increased pyruvate concentrations) is linked at least in
part to epinephrine induced 𝛽
2
-stimulation of sarcolemmal
Na+-K+-ATPase [24, 25].
In most patients with severe sepsis, the hepatosplanchnic
region as a whole does not produce lactate [26]. This was
also the case in peritonitis in the present study, where the
hepatic-venous-arterial lactate gradient remained negative
throughout the experiment.
Our study has important limitations. It has been shown in
rabbits that fasting prevents or attenuates endotoxin-induced
systemic and hepatic blood flow reduction, metabolic aci-
dosis, and hyperglycemia which are observed in fed ani-
mals [27]. We cannot therefore exclude that feeding our
animals until sepsis inductionwould have revealed a different
metabolic (and maybe hemodynamic) response. Small doses
of heparin infused to maintain intravenous catheter patency
in our study may theoretically have interfered with the
inflammatory profile in peritonitis animals [28]. In cardiac
tamponade, the increased central venous pressures related to
the model may have reduced the hepatic blood flow more
than in cardiogenic shock caused by other mechanisms. This
may have contributed to the net hepatic lactate production.
The peritonitis model was fluid resuscitated throughout
the study. In clinical sepsis, a variable delay in starting
fluid resuscitation may modify both the etiology of lactate
production and the lactate kinetics.
In conclusion, we found that venous lactate efflux from
the systemic circulation was of a similar magnitude in
peritonitis and in severe cardiogenic shock. In peritonitis,
this was the consequence of an early increase in peripheral,
extrasplanchnic, and extrarenal lactate production without
signs of tissue hypoxia but impaired capability to increase
BioMed Research International 7
hepatic lactate uptake. In cardiogenic shock, the increased
venous lactate efflux was the result of increased net lactate
release from both the periphery and from the liver.
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